Small Airway Dysfunction in Rheumatoid Arthritis and Systemic Sclerosis
Key facts
- Where
- Paris, FranciaországSee the site
Where in Franciaország
- Rheumatology Department, Cochin HospitalParis, FranciaországNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Assistance Publique - Hôpitaux de Paris
- Trial code
- NCT07924124
- Record updated
- 2026. november 9.
- Original description
The purpose of this prospective real-world study is to assess the presence and severity of small airway dysfunction in patients with rheumatoid arthritis or systemic sclerosis and to examine the relationships between the various markers of small airway dysfunction and disease activity.Read full original descriptionShow less
Study on Small Airway Dysfunction in Rheumatoid Arthritis and Systemic Sclerosis
The purpose of this prospective real-world study is to assess the presence and severity of small airway dysfunction in patients with rheumatoid arthritis or systemic sclerosis and to examine the relationships between the various markers of small airway dysfunction and disease activity.
Inclusion: Patients ≥ 18 years of age; Diagnosis of rheumatoid arthritis (RA) or systemic sclerosis (SSc) confirmed by a rheumatologist; Patients affiliated with or covered by a social security scheme; Patients who have received information regarding the research and have signed the consent form.
Exclusion: Presence of interstitial lung disease (ILD) identified prior to recruitment; History of treatment with medications known to induce pulmonary fibrosis (bleomycin, amiodarone) or prior radiation therapy for the local treatment of thoracic malignancies (breast cancer, lung cancer); Patients unable to perform any of the following pulmonary function tests (PFTs):; Impulse oscillometry (IOS); Forced spirometry; Measurement of lung volumes via plethysmography; Individuals covered under Articles L1121-5 to 1121-8 of the French Public Health Code (minors, adults under legal guardianship or curatorship, individuals deprived of their liberty, pregnant or breastfeeding women); Patients who do not understand the French language.